INVO Fertility (IVF) announced it has received a notice of allowance on a new patent for a modified version of the Company’s proprietary INVOcell device. The new patent extends intellectual property protection on the Company’s INVOcell device through 2040 based on a modified design which reflects feedback from leading embryologists to simplify use of the device. The United States Patent and Trademark Office, USPTO, has issued a Notice of Allowance for U.S. Patent Application No. 16/949,960, titled “Intravaginal Culture Incubation Container and Method.” The Notice of Allowance, dated June 17, 2025, indicates that the USPTO has completed its examination and found the claims patentable. Once the issue fee is paid, the patent will be granted and published, providing protection to the claimed invention for 20 years from the filing date.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVF:
- INVO Fertility recommends shareholders vote for all proposals at Annual Meeting
- INVO Fertility expands telehealth capabilities at Wisconsin Fertility Institute
- INVO Fertility Restructures Financial Agreements Amid Leadership Change
- INVO Fertility Reports Q1 2025 Financial Results
- INVO Fertility Delays Q1 2025 10-Q Filing